• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直肠癌标本中辐射诱导的基因表达变化。

Radiation-induced changes in gene expression in rectal cancer specimens.

机构信息

Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1QH, UK.

The Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.

出版信息

Clin Transl Oncol. 2024 Jun;26(6):1419-1428. doi: 10.1007/s12094-023-03361-9. Epub 2024 Jan 19.

DOI:10.1007/s12094-023-03361-9
PMID:38243085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11108951/
Abstract

PURPOSE

The standard-of-care for locally advanced rectal cancer is radiotherapy-based neoadjuvant therapy followed by surgical resection. This article reviews the evidence of molecular changes at the transcriptome level induced through radiotherapy in rectal cancer.

METHODS

The PubMed search "(radiation OR radiotherapy) cancer (transcriptome OR "gene expression") rectal" was used. The studies taken forward utilised gene-expression data on both pre-treatment and post-treatment rectal adenocarcinoma biospecimens from patients treated with RT-based neoadjuvant strategies.

RESULTS

Twelve publications met the review criteria. There was variation in approaches in terms of design, patient population, cohort size, timing of the post-radiotherapy sampling and method of measuring gene expression. Most of the post-treatment biospecimen retrievals were at resection. The literature indicates a broad upregulation of immune activity through radiotherapy using gene-expression data.

CONCLUSION

Future studies would benefit from standardised prospective approaches to sampling to enable the inclusion of timepoints relevant to the tumour and immune response.

摘要

目的

局部晚期直肠癌的标准治疗方法是基于放疗的新辅助治疗,然后进行手术切除。本文综述了放疗在直肠癌中诱导转录组水平分子变化的证据。

方法

使用 PubMed 搜索“(radiation OR radiotherapy) cancer (transcriptome OR "gene expression") rectal”。纳入的研究采用了基于 RT 的新辅助策略治疗的直肠腺癌生物标本的预处理和后处理基因表达数据。

结果

有 12 篇文献符合审查标准。在设计、患者人群、队列大小、放疗后取样时间以及测量基因表达的方法等方面存在差异。大多数的后处理生物标本都是在切除时获取的。文献表明,通过基因表达数据,放疗广泛地上调了免疫活性。

结论

未来的研究将受益于标准化的前瞻性采样方法,以便纳入与肿瘤和免疫反应相关的时间点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed37/11108951/fb7e5c9aefd0/12094_2023_3361_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed37/11108951/2ca947a76155/12094_2023_3361_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed37/11108951/b774a075286e/12094_2023_3361_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed37/11108951/fb7e5c9aefd0/12094_2023_3361_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed37/11108951/2ca947a76155/12094_2023_3361_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed37/11108951/b774a075286e/12094_2023_3361_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed37/11108951/fb7e5c9aefd0/12094_2023_3361_Fig3_HTML.jpg

相似文献

1
Radiation-induced changes in gene expression in rectal cancer specimens.直肠癌标本中辐射诱导的基因表达变化。
Clin Transl Oncol. 2024 Jun;26(6):1419-1428. doi: 10.1007/s12094-023-03361-9. Epub 2024 Jan 19.
2
Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer.新辅助放化疗改变局部晚期直肠癌抗肿瘤免疫治疗反应的生物标志物。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001610.
3
Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer.与新辅助放疗治疗直肠癌时的重编程微环境和病毒模拟相关的免疫基因的差异和纵向模式。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001717.
4
Global DNA methylation is altered by neoadjuvant chemoradiotherapy in rectal cancer and may predict response to treatment - A pilot study.直肠癌新辅助放化疗可改变全基因组DNA甲基化水平,且可能预测治疗反应——一项初步研究
Eur J Surg Oncol. 2014 Nov;40(11):1459-66. doi: 10.1016/j.ejso.2014.06.008. Epub 2014 Jul 28.
5
Does chronomodulated radiotherapy improve pathological response in locally advanced rectal cancer?时辰调制放疗能否改善局部晚期直肠癌的病理反应?
Chronobiol Int. 2017;34(4):492-503. doi: 10.1080/07420528.2017.1301462. Epub 2017 Mar 29.
6
Early dynamic transcriptomic changes during preoperative radiotherapy in patients with rectal cancer: a feasibility study.直肠癌患者术前放疗过程中的早期动态转录组学变化:一项可行性研究。
World J Gastroenterol. 2013 Jun 7;19(21):3249-54. doi: 10.3748/wjg.v19.i21.3249.
7
MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.与局部晚期直肠癌患者新辅助放化疗反应相关的 microRNA 表达谱。
Radiat Oncol. 2012 Nov 20;7:195. doi: 10.1186/1748-717X-7-195.
8
YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.直肠癌活检组织中YKL-40/c-Met表达可预测新辅助放化疗后的肿瘤退缩:一项多机构研究
PLoS One. 2015 Apr 15;10(4):e0123759. doi: 10.1371/journal.pone.0123759. eCollection 2015.
9
Wnt-signaling and apoptosis after neoadjuvant short-term radiotherapy for rectal cancer.直肠癌新辅助短期放疗后的Wnt信号传导与细胞凋亡
Int J Oncol. 2004 Dec;25(6):1543-9.
10
Effect of preoperative radiotherapy on matrilysin gene expression in rectal cancer.术前放疗对直肠癌中基质溶解素基因表达的影响。
Eur J Cancer. 2002 Mar;38(4):505-10. doi: 10.1016/s0959-8049(01)00392-6.

本文引用的文献

1
Identification of four immune subtypes in locally advanced rectal cancer treated with neoadjuvant chemotherapy for predicting the efficacy of subsequent immune checkpoint blockade.在接受新辅助化疗治疗局部晚期直肠癌的患者中,识别四种免疫亚型可预测后续免疫检查点阻断的疗效。
Front Immunol. 2022 Sep 27;13:955187. doi: 10.3389/fimmu.2022.955187. eCollection 2022.
2
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer.直肠癌新辅助治疗反应的基因组和转录组决定因素。
Nat Med. 2022 Aug;28(8):1646-1655. doi: 10.1038/s41591-022-01930-z. Epub 2022 Aug 15.
3
Biomarkers for Predicting the Response to Radiation-Based Neoadjuvant Therapy in Rectal Cancer.
用于预测直肠癌放射治疗新辅助治疗反应的生物标志物。
Front Biosci (Landmark Ed). 2022 Jun 27;27(7):201. doi: 10.31083/j.fbl2707201.
4
Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).度伐鲁单抗(MEDI 4736)联合延长新辅助方案治疗直肠癌的随机 II 期研究(PRIME-RT)方案。
Radiat Oncol. 2021 Aug 26;16(1):163. doi: 10.1186/s13014-021-01888-1.
5
Assessment of the expression and response of PD-1, LAG-3, and TIM-3 after neoadjuvant radiotherapy in rectal cancer.评估新辅助放疗后直肠癌中 PD-1、LAG-3 和 TIM-3 的表达和反应。
Neoplasma. 2021 Jul;68(4):742-750. doi: 10.4149/neo_2021_201210N1341. Epub 2021 Apr 13.
6
Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer.新辅助放化疗改变局部晚期直肠癌抗肿瘤免疫治疗反应的生物标志物。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001610.
7
Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer.与新辅助放疗治疗直肠癌时的重编程微环境和病毒模拟相关的免疫基因的差异和纵向模式。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001717.
8
Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis.局部晚期直肠癌的新辅助治疗与标准治疗的比较:系统评价和荟萃分析。
JAMA Netw Open. 2020 Dec 1;3(12):e2030097. doi: 10.1001/jamanetworkopen.2020.30097.
9
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.短程放疗联合化疗后行全直肠系膜切除术(TME)与术前放化疗、TME 及辅助化疗在局部进展期直肠癌(RAPIDO)中的应用:一项随机、开放标签、3 期临床试验。
Lancet Oncol. 2021 Jan;22(1):29-42. doi: 10.1016/S1470-2045(20)30555-6. Epub 2020 Dec 7.
10
Effect of preoperative chemoradiotherapy on the immunological status of rectal cancer patients.术前放化疗对直肠癌患者免疫状态的影响。
J Radiat Res. 2020 Sep 8;61(5):766-775. doi: 10.1093/jrr/rraa041.